Robyn Frick
Corporate Officer/Principal bei Bazelet Health Systems, Inc.
Profil
Robyn Frick is currently the Chief Learning Officer at Bazelet Health Systems, Inc. Previously, Mr. Frick worked as the President at Neon Bloom, Inc.
Aktive Positionen von Robyn Frick
| Unternehmen | Position | Beginn |
|---|---|---|
Bazelet Health Systems, Inc.
 Bazelet Health Systems, Inc. Pharmaceuticals: OtherHealth Technology Part of Neon Bloom, Inc., Bazelet Health Systems, Inc. is a licensed plant patent, trademark, and manufacturer of pan2020, the world's first patented cannabis plant. The company is based in Pine City, NY. Bazelet™ developed the proprietary ingredient pecsa™, used in the manufacturing and commercial supply of food, drug, and cosmetic products that comply with the food, drug and cosmetic act. The American company was founded by David Grand. Bazelet Health Systems was acquired by Neon Bloom, Inc. on March 18, 2021 for $177.60 million. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Robyn Frick
| Unternehmen | Position | Ende |
|---|---|---|
| NEON BLOO | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEON BLOO | Finance |
| Private Unternehmen | 1 |
|---|---|
Bazelet Health Systems, Inc.
Bazelet Health Systems, Inc. Pharmaceuticals: OtherHealth Technology Part of Neon Bloom, Inc., Bazelet Health Systems, Inc. is a licensed plant patent, trademark, and manufacturer of pan2020, the world's first patented cannabis plant. The company is based in Pine City, NY. Bazelet™ developed the proprietary ingredient pecsa™, used in the manufacturing and commercial supply of food, drug, and cosmetic products that comply with the food, drug and cosmetic act. The American company was founded by David Grand. Bazelet Health Systems was acquired by Neon Bloom, Inc. on March 18, 2021 for $177.60 million. | Health Technology |
